INCREASED PLASMA-CONCENTRATION OF CROSS-LINKED FIBRIN POLYMERS IN ACUTE MYOCARDIAL-INFARCTION

被引:105
|
作者
FRANCIS, CW
CONNAGHAN, DG
SCOTT, WL
MARDER, VJ
机构
关键词
D O I
10.1161/01.CIR.75.6.1170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1170 / 1177
页数:8
相关论文
共 50 条
  • [1] INCREASED PLASMA-CONCENTRATION OF CROSS-LINKED FIBRIN POLYMERS IN ACUTE MYOCARDIAL-INFARCTION
    FRANCIS, CW
    CONNAGHAN, DG
    SCOTT, WL
    MARDER, VJ
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 268 - 268
  • [2] PLASMA-CONCENTRATION OF CROSS-LINKED FIBRIN DEGRADATION PRODUCT (D-DIMER) AND THE RISK OF FUTURE MYOCARDIAL-INFARCTION AMONG APPARENTLY HEALTHY-MEN
    RIDKER, PM
    HENNEKENS, CH
    CERSKUS, A
    STAMPFER, MJ
    CIRCULATION, 1994, 90 (05) : 2236 - 2240
  • [3] ASSESSMENT OF CROSS-LINKED FIBRIN DEGRADATION PRODUCTS DURING FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
    FRANCIS, CW
    CONNAGHAN, DG
    MARDER, VJ
    CIRCULATION, 1986, 74 (04) : 94 - 94
  • [4] PLASMA-CONCENTRATION OF HDL-CHOLESTEROL IN THE COURSE OF ACUTE MYOCARDIAL-INFARCTION
    GARFAGNINI, A
    MASSETTI, L
    BECCHI, G
    MINERVA CARDIOANGIOLOGICA, 1982, 30 (04): : 171 - 178
  • [5] Increased plasma concentration of fibrin monomer in acute myocardial infarction with early reperfusion
    Spiecker, M
    Hafner, G
    Nixdorff, U
    Prellwitz, W
    Meyer, J
    CORONARY ARTERY DISEASE, 1996, 7 (02) : 155 - 160
  • [6] CLINICAL-APPLICATIONS OF THE MEASUREMENT OF CROSS-LINKED FIBRIN DEGRADATION PRODUCTS FOLLOWING MYOCARDIAL-INFARCTION
    ROWBOTHAM, B
    WHITAKER, AN
    BETT, JDN
    WOODHOUSE, SP
    BUNCE, IH
    ELMS, MJ
    MASCI, P
    WEBBER, AJ
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 231 - 231
  • [7] ELEVATED SERUM D DIMER, A DEGRADATION PRODUCT OF CROSS-LINKED FIBRIN (XDP) FOLLOWING INTRAVENOUS STREPTOKINASE DURING ACUTE MYOCARDIAL-INFARCTION
    LEW, AS
    BERBERIAN, L
    LARAMEE, P
    CERCEK, B
    LEE, S
    HOD, H
    SHAH, PK
    GANZ, W
    CLINICAL RESEARCH, 1986, 34 (01): : A10 - A10
  • [8] The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction
    Lee, LV
    Ewald, GA
    McKenzie, CR
    Eisenberg, PR
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) : 628 - 633
  • [9] SPECIFIC DETERMINATION AND IDENTIFICATION OF CROSS-LINKED FIBRIN DEGRADATION PRODUCTS IN PATIENTS UNDER THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION
    SORIA, J
    SORIA, C
    MIRSHAHI, M
    XI, M
    MIRSHAHI, M
    SAMAMA, MM
    CAEN, JP
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1987, 13 (02): : 223 - 227
  • [10] PROPHYLACTIC DISOPYRAMIDE - ITS CLINICAL EFFECTS RELATED TO PLASMA-CONCENTRATION IN MYOCARDIAL-INFARCTION
    HILLSON, RM
    BOYD, E
    CUNNINGHAM, J
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1980, 8 (05) : 314 - 320